These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6691946)
1. The symptomatology of the climacteric in relation to hormonal and cytological factors. James CE; Breeson AJ; Kovacs G; Hill JG; Grant C; Allen KM; Fry DE; Baylis EM Br J Obstet Gynaecol; 1984 Jan; 91(1):56-62. PubMed ID: 6691946 [TBL] [Abstract][Full Text] [Related]
2. Relation between plasma oestrone and oestradiol and climacteric symptoms. Hutton JD; Jacobs HS; Murray MA; James VH Lancet; 1978 Apr; 1(8066):678-81. PubMed ID: 76222 [TBL] [Abstract][Full Text] [Related]
3. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause. Chakravarti S; Collins WP; Thom MH; Studd JW Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937 [TBL] [Abstract][Full Text] [Related]
4. Relation between the karyopyknotic index and plasma oestrogen concentrations after the menopause. Morse AR; Hutton JD; Jacobs HS; Murray MA; James VH Br J Obstet Gynaecol; 1979 Dec; 86(12):981-3. PubMed ID: 526457 [TBL] [Abstract][Full Text] [Related]
5. Climacteric symptoms in an unselected sample of Swedish women. Hammar M; Berg G; Fåhraeus L; Larsson-Cohn U Maturitas; 1984 Dec; 6(4):345-50. PubMed ID: 6533438 [TBL] [Abstract][Full Text] [Related]
6. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms. Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462 [TBL] [Abstract][Full Text] [Related]
8. The effects of various estrogenic preparations; changes in the vaginal mucosa and general status of climacteric women following the injection of aqueous suspensions of estrone and estradiol. VOGEL M; McGAVACK TH; MELLOW J Am J Obstet Gynecol; 1949 Apr; 57(4):682-91. PubMed ID: 18124553 [No Abstract] [Full Text] [Related]
10. Clinical and endocrine studies in menopausal women after estradiol pellet implantation. Nagamani M; Lin TJ; McDonough PG; Watatani H; McPherson JC; Mahesh VB Obstet Gynecol; 1977 Nov; 50(5):541-7. PubMed ID: 909658 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of estradiol vaginal cream in postmenopausal women. Dickerson J; Bressler R; Christian CD; Hermann HW Clin Pharmacol Ther; 1979 Oct; 26(4):502-7. PubMed ID: 226306 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I]. Savoca S; D'Agosta S; Lombardo G Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors. Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709 [TBL] [Abstract][Full Text] [Related]
14. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Lobo RA; McCormick W; Singer F; Roy S Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy]. Yasui T; Uemura H; Yoneda N; Irahara M; Aono T; Sunahara S; Hata K Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):655-61. PubMed ID: 7636337 [TBL] [Abstract][Full Text] [Related]
16. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ Menopause; 2009; 16(1):132-40. PubMed ID: 18971794 [TBL] [Abstract][Full Text] [Related]
17. The significance of oestriol in the management of the post-menopause. Tzingounis VA; Aksu MF; Greenblatt RB Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286 [TBL] [Abstract][Full Text] [Related]
18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516 [TBL] [Abstract][Full Text] [Related]
19. Patterns of luteinizing and follicle-stimulating hormone pulsatility in menopausal women: correlation with plasma testosterone level and vasomotor instability episodes. Fossum GT; Greep N; Kletzky OA Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):795-800. PubMed ID: 7573246 [TBL] [Abstract][Full Text] [Related]
20. [Urinary excretion of estrogens in women with bleeding during climacteric and in menopause]. Grudzień M Pol Tyg Lek; 1970 Sep; 25(39):1447-9. PubMed ID: 5470643 [No Abstract] [Full Text] [Related] [Next] [New Search]